Canadian Organization for Rare Disorders (CORD)
Canadian Organization for Rare Disorders (CORD) is Canada’s national network for organizations representing all those with rare disorders. CORD provides a strong common voice to advocate for health policy and a healthcare system that works for those with rare disorders. CORD works with governments, researchers, clinicians and industry to promote research, diagnosis, treatment and services for all rare disorders in Canada.
During 2015, GSK funded the Canadian Organization for Rare Disorders with:
- $10,000 in corporate funding in support of CORD Corporate Leaders Forum
- $5,000 in project funding for 2015 Rare Disease Day Conference
GSK’s contributions represent less than 4.7% of the organization’s total revenue for 2015.